top of page

Search


Peptide 16AC + Nopayne Rabbit Trial Approved
Pharmachal and its Israeli collaboration partner Rambam Medtech are pleased to announce that approval has been granted to commence rabbit...
Jan 29


Aust. N.Z. Burns Association Presentation on NOPAYNE
In October, Dr Lourdes Santiso, Head of the Paediatric Burns Unit at the Roosevelt Hospital in Guatemala City, presented to the Australia...
Jan 20


Pharmachal and Rambam Medtech Take Giant Step Towards 3-in-1: Coagulation + Local anaesthesia + Accelerated Healing Product
March 27, 2024 - Melbourne, Australia & Haifa, Israel:Â Pharmachal Health Group and its Israeli partner Rambam MedTech have received the...
Mar 26, 2024


Pharmachal Signs Agreement with Rambam, Israel to Develop 'Ultimate 3-in-1 wound healing technology
Pharmachal Health Group and tier-1 Israeli trauma hospital Rambam Healthcare Campus have signed an agreement to develop a new product for...
Jan 16, 2023


PHARMACHAL LICENSES NOVEL ANTI-VIRAL CAPSULE IN FIGHT AGAINST COVID-19
Melbourne pharmaceutical company Pharmachal Health Group has secured regional distribution for the novel, broad-spectrum antiviral...
Aug 24, 2021


Guatemalan Volcano Burns Victims Treated with NOPAYNE
8 August, 2018 When the Volcan de Fuego (Fire Volcano) in Guatemala erupted in June, over 100 people died, another two hundred went...
Aug 9, 2018
bottom of page